Anavex Life Sciences Corp (AVXL)

[tradeherpete]

What has management been doing?

Anavex has been producing the leading contender in the Alzheimer's Neurology space.

They are #1 with a bullet scheduled for approval in 2025. The Marketing Authorisation would allow direct market access throughout the European Union for oral blarcamesine for the treatment of Alzheimer’s disease.

They have data and safety which line up with the latest guidance from the FDA and the EMA has seen it. Having seen it, the EMA has requested Anavex submit for full approval for Alzheimer's Disease.

That's what Anavex has been doing.

All the other companies are fumbling about with drugs and trials unable to even considering applying for approval. The ones that have received FDA approval are very poor substitutes for a safe therapeutic drug.